Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment. Take 2 mins to learn more.

News & Insights

Biofidelity completes a successful study in collaboration with Agilent Technologies

Biofidelity has announced the successful completion of a study to detect key lung cancer mutations in collaboration with Agilent Technologies, a global leader in life sciences, diagnostics and applied chemicals.

The study showed an improvement in sensitivity of 50 times that achieved by current FDA approved methods.


Click here for the official company press release